Latest News about INCY
Recent news which mentions INCY
Stocks Move Higher, Walmart Hits Record High, Natural Gas Reaches 5-Month Peak: What's Driving Markets Tuesday?
November 19, 2024
From Benzinga
What's Going On With Incyte Shares Tuesday?
November 19, 2024
From Benzinga
Aecom Reports Q4 Results, Joins Incyte And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
November 19, 2024
From Benzinga
Incyte's $750 Million Escient Deal Faces Setback With Toxicology Issues In Two Investigational Drugs, Analyst Flags Challenges
November 19, 2024
From Benzinga
Nasdaq Gains 100 Points; Lowe's Earnings Beat Views
November 19, 2024
From Benzinga
Why Symbotic Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket
November 19, 2024
From Benzinga
Cracking The Code: Understanding Analyst Reviews For Incyte
November 14, 2024
Tickers
INCY
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
November 13, 2024
From Benzinga
Incyte's Jakafi Demand Is Strong, Analyst Upgrades Stock
October 30, 2024
From Benzinga
Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights
October 30, 2024
From Benzinga
From Benzinga
Incyte Clocks Mixed Q3 Earnings, But Analyst Sees A Strong Quarter For Jakafi And Opzelura
October 29, 2024
From Benzinga
Corning Posts Upbeat Q3 Earnings, Joins Opera, Inari Medical, Incyte And Other Big Stocks Moving Higher On Tuesday
October 29, 2024
From Benzinga
Peeling Back The Layers: Exploring Incyte Through Analyst Insights
October 23, 2024
Tickers
INCY
From Benzinga
A Look Into Incyte Inc's Price Over Earnings
October 10, 2024
From Benzinga
Optimism Around Aquestive As it Moves Forward With Severe Allergy, Baldness Candidate
September 30, 2024
From Benzinga
Incyte Downgraded - Analyst Notes Intense Competition, Particularly In Larger Markets
September 18, 2024
From Benzinga
Incyte Stock: A Deep Dive Into Analyst Perspectives (9 Ratings)
September 03, 2024
Tickers
INCY
From Benzinga
Incyte Seeks Expanded FDA Approval For Lymphoma Drug After Releasing Promising Topline Data From Late-Stage Study
August 16, 2024
From Benzinga
FDA Approves Incyte/Syndax Partnered Drug For Chronic Graft-Versus-Host Disease, A Post-Transplant Complication
August 15, 2024
From Benzinga
After Reporting Five Patient Deaths, Data Committee Recommends MacroGenics Halt Prostate Cancer Trial
July 31, 2024
From Benzinga
Incyte's Q2 Earnings: Wider Than Expected Loss, Pipeline Review, Lifts Jakafi Sales Guidance
July 30, 2024
From Benzinga
From Benzinga
From InvestorPlace
7 Cheap Biotech Stocks With Major Upside Potential
July 09, 2024
From InvestorPlace
3 Highly Rated Biotech Stocks for Your July Buy List
July 05, 2024
From InvestorPlace
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.